Vital Psychedelic Training by Psychedelics Today is a 12-month professional certificate training program covering the elements of psychedelic therapy and integration, beginning again in October 2024.
This year-long course is designed to provide a multidisciplinary approach to psychedelic therapy, covering medical, academic, transpersonal, indigenous, somatic, and trauma-informed models. Students will experience the transformational power of psychedelics and non-ordinary states of consciousness at one of the course’s residential retreats. The course will explore the intersectionality between Western medicine, psychedelic therapy, and holistic therapeutic modalities. Students can build a community of fellow psychedelic practitioners on a shared mission to support the world’s healing and evolution.
The course will cover the skills related to screening, preparing, navigating, holding space, and integrating a psychedelic journey in a safe and ethical container that honours each client’s needs. Students will also have the opportunity to personalize their learning journey by choosing elective modules and masterclasses that suit their individual learning goals. The course will also feature lectures from some of the world’s leading experts, researchers, and practitioners.
The course structure includes weekly live lectures, a 2-hour webinar taught by a special guest and followed up by Q&A, weekly study groups, electives, experiential retreats, peer study groups (optional), monthly webinars, an online community platform, and a final project. To graduate, students must attend all five core and two elective modules, participate in one experiential retreat, and complete a final certification project. The tuition fee for the course is $10,000 and includes 180 hours of live lectures, study groups, one four-week elective module, and one residential retreat.
Vital was designed for medical professionals who want to incorporate psychedelic knowledge and integration modalities into their therapeutic practice. Notable teaching staff include Rick Strassman, Bill Richards, Adele Lafrance, and Reid Robinson.
Find More Info on Vital Psychedelic Training on PsychedelicsCourses.com
Related Company
Psychedelics Today
Psychedelics Today is an educational website that offers courses on psychedelics and their therapeutic applications. Psychedelics Today is also known for its long-running podcast (nearing 400 episodes), which has featured guests like Matthew Johnson, James Fadiman, and David Nutt.
Related People
Kyle Buller
Kyle is one of the founders of Psychedelics Today. He is quite influential in steering the psychedelics conversation and both his respect for traditional ways of using psychedelics, and knowledge of the latest research, and a healthy dose of critique, make for a great moderator.
Ben Sessa
Ben Sessa is psychedelics researcher, psychotherapist, advocate for legalization, author, co-founder of Breaking Convention, and Chief Medical Officer at AWAKN Life Sciences.
Rick Strassman
Rick Strassman is an associate professor of psychiatry and best known for his DMT research in the late 1990s and his subsequent book DMT: The Spirit Molecule.
Bill Richards
William A. 'Bill' Richards is one of the pioneering psychedelic researchers (Johns Hopkins), a teacher at CIIS, and clinician in private practice.
Michael Mithoefer
Michael Mithoefer is a psychiatrist and a Clinical Investigator and acting Medical Director of MAPS Public Benefit Corporation.
Reid Robison
Reid Robison is CMO at Novamind.
Sam Gandy
Sam Gandy has been working on psychedelics at Imperial College London and the Beckley Foundation, here he studies how psychedelics reconnect us to nature.
David Luke
David Luke is Senior Lecturer in Psychology at the University of Greenwich, where he has been teaching an undergraduate course on the Psychology of Exceptional Human Experience since 2009, and also Honorary Senior Lecturer at the Centre for Psychedelic Research, Imperial College. His research focuses on transpersonal experiences, anomalous phenomena, and altered states of consciousness, especially via psychedelics, having published more than 100 academic papers in this area, including ten books.